CASI PHARMACEUTICALS INC (CASIF)
- Open
- 0.1170
- High
- 0.1170
- Low
- 0.1170
- Prev. Close
- 0.1170
- Volume
- 1.03K
- Turnover
- 119.93
- Avg Price
- 0.1170
- Bid/Ask Ratio
- --
- Amplitude
- 0.00%
- 52wk High
- 2.1300
- Volume Ratio
- 0.85
- Turnover Ratio
- 0.01%
- 52wk Low
- 0.0500
- Float Mkt Cap
- 1.14M
- Market CapUSD
- 2.41M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -2.14
- EPSDynamic
- -1.95
- EPSStatic
- --
- BVPS
- -2.83
- P/B
- --
- Circulating Supply
- 9.72M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 20.56M
- Min lot size
- 1
- Currency
- USD
News
- PUBT · Sep 2 at 11:02 AM
CASI Pharmaceuticals sells Alesta stake to BioMarin for US$5.9 million
- PUBT · Aug 14 at 10:45 AM
CASI net loss narrows to USD 20 million in H1 FY26; revenue falls 5.8% to USD 9.8 million
- StockTitan · Aug 14 at 02:45 AM
CASI Pharmaceuticals Announces First Half 2026 Business and Financial Results | CASIF Stock News
- PUBT · Aug 13 at 08:38 PM
CASI Pharmaceuticals says SVP Wei (Larry) Zhang steps down
- PUBT · Jul 15 at 10:31 AM
CASI wins HKIAC arbitration award topping RMB 100 million against Juventas
- PUBT · Jul 1 at 12:17 PM
CASI doses first patient in Phase 1/2 CID-103 trial for renal allograft antibody-mediated rejection in China
